Cornea & Anterior Segment Services, MGM Eye Institute, Raipur, Chhattisgarh, India.
Cornea. 2020 Jan;39(1):39-44. doi: 10.1097/ICO.0000000000002044.
To determine the factors responsible for the recurrence of infection after therapeutic penetrating keratoplasty (TPK) in severe microbial keratitis.
This is a retrospective interventional case series that reviewed the medical records of 229 consecutive patients (2005-2017) who underwent TPK for microbial keratitis at a tertiary eye care center in Central India. The primary outcome was recurrence of the primary infection. The factors responsible for recurrence were identified by univariate and multivariate regression analysis.
The overall outcomes were clear graft in 50 (21.8%) eyes, failed graft in 139 (60.7%) eyes, evisceration in 19 (8.3%) eyes, phthisis bulbi in 14 (6.1%) eyes, repeat TPK in 2 (0.9%) eyes, and anterior staphyloma in 1 (0.4%) eye. Recurrence occurred in 63 (27.5%) eyes within 16.2 ± 13.8 (range: 2-66) days. Univariate analysis identified fungal etiology (P = 0.001), ulcer size > 60 mm (P = 0.001), limbal involvement (P = 0.001), endothelial exudates (P = 0.024), retro-iris exudates (P = 0.001), corneal perforation (P = 0.005), coexisting endophthalmitis (P < 0.001), and graft size ≥ 10 mm (P < 0.001) as significant risk factors. Multiple logistic regression identified fungal etiology (P = 0.013), retro-iris exudates (P = 0.011), coexisting endophthalmitis (P = 0.004), and graft size ≥ 10 mm (P = 0.058) as independent risk factors for recurrence. Presenting visual acuity of 20/200 or better was seen in 49 (21.4%) and 39 (17%) eyes, and no light perception in 11 (4.8%) and 26 (11.4%) eyes at postoperative months 1 and 3, respectively.
Fungal etiology, retro-iris exudates, coexisting endophthalmitis, and larger grafts were susceptible to recurrence. Early surgery may mitigate most of these factors. Despite the risk of recurrence, TPK remains an effective treatment in severe nonresponsive keratitis.
确定治疗性穿透性角膜移植术(TPK)后严重微生物角膜炎感染复发的相关因素。
这是一项回顾性的干预性病例系列研究,回顾了 2005 年至 2017 年间在印度中部一家三级眼科中心接受 TPK 治疗微生物角膜炎的 229 例连续患者(2005-2017 年)的病历。主要结局是原发性感染的复发。通过单变量和多变量回归分析确定与复发相关的因素。
总体结局为 50 只眼(21.8%)透明移植片,139 只眼(60.7%)移植失败,19 只眼(8.3%)眼内容剜除,14 只眼(6.1%)眼球萎缩,2 只眼(0.9%)重复 TPK,1 只眼(0.4%)眼前部葡萄肿。63 只眼(27.5%)在 16.2±13.8 天(范围:2-66 天)内复发。单变量分析发现真菌病因(P=0.001)、溃疡面积>60mm(P=0.001)、角膜缘受累(P=0.001)、内皮细胞渗出(P=0.024)、虹膜后渗出(P=0.001)、角膜穿孔(P=0.005)、并存眼内炎(P<0.001)和移植物大小≥10mm(P<0.001)是显著的危险因素。多变量逻辑回归分析确定真菌病因(P=0.013)、虹膜后渗出(P=0.011)、并存眼内炎(P=0.004)和移植物大小≥10mm(P=0.058)是复发的独立危险因素。术后 1 个月和 3 个月时,分别有 49 只眼(21.4%)和 39 只眼(17%)的最佳矫正视力为 20/200 或更好,11 只眼(4.8%)和 26 只眼(11.4%)无光感。
真菌病因、虹膜后渗出、并存眼内炎和较大的移植物容易复发。早期手术可能减轻大多数这些因素。尽管有复发的风险,但 TPK 仍然是严重反应性角膜炎的有效治疗方法。